Psilocybin—the active ingredient in "magic" mushrooms—is a more effective treatment for symptoms of depression than controls, providing further support for its potential as an antidepressant, suggests a study published ...
May 1, 2024
0
57
New research suggests psilocybin has similar side effects to traditional antidepressants. Commonly referred to as "magic mushrooms," psilocybin is a promising alternative treatment for people with medication-resistant depression ...
Apr 23, 2024
0
99
A recent study suggests that mushroom extract containing psilocybin may exhibit superior efficacy when compared to chemically synthesized psilocybin. The findings are published in the journal Molecular Psychiatry.
Mar 11, 2024
0
82
Calls to U.S. poison centers involving psilocybin, or "magic mushrooms," among adolescents and young adults rose sharply after several U.S. cities and states began decriminalizing the hallucinogen, University of Virginia ...
Feb 26, 2024
0
0
Seizures by law enforcement officials of psilocybin, a compound found in psychedelic mushrooms, have increased by 369% since 2017, a new study shows. The authors say their findings may signal growing availability and public ...
Feb 6, 2024
0
1
Nearly 4 out of 5 Canadians believe that the use of psilocybin, the active ingredient in hallucinogenic mushrooms, is an acceptable medical approach to treat existential distress in patients suffering from a serious and incurable ...
Jan 23, 2024
0
0
New Jersey lawmakers have introduced a bill that would make it the third state to legalize "magic mushrooms."
Jan 19, 2024
0
1
An Indiana Senate bill seeking funding for research into medical applications of psilocybin was passed unanimously by the Senate Committee on Health and Provider Services on Wednesday.
Jan 19, 2024
0
0
Rapid-acting antidepressants, including ketamine, scopolamine and psilocybin, have been found to have immediate and lasting positive effects on mood in patients with major depressive disorder but how these effects arise is ...
Jan 10, 2024
0
103
A team of anesthesiologists at the University of Michigan, working with a pair of colleagues from Tryp Therapeutics, has found, via experimentation, that rats can experience a reduction in chronic pain when given injections ...
